A HISTORY OF GLOBAL SOLUTIONS
The Jean Boulle Group acquires promising assets and projects and optimizes their structure, management and development with private and public investment.
NEWS AND MEDIA
Trained Therapeutix Discovery appoints Nobel Laureate Dr. James Allison, Dr. Padmanee Sharma, and Dr. Mihai Netea to its Scientific Advisory Board
19th April, 2021
Trained Therapeutix Discovery (“TTxD”) announces that it has extended its Scientific Advisory Board to include James P. Allison, Ph.D. and Padmanee Sharma, M.D., Ph.D. Dr. Allison received the 2018 Nobel Prize in Physiology or Medicine for his work on discovering immune checkpoint blockade and is the Regental Professor and Chair of the Department of Immunology, the Olga Keith Wiess Distinguished University Chair for Cancer Research, Director of the Parker Institute for Cancer Research, and the Executive Director of the Immunotherapy Platform at MD Anderson Cancer Center. Dr. Sharma is a pioneer and world-renowned expert in designing and running immuno-oncology clinical trials and is a practicing immunologist and oncologist at MD Anderson Cancer Center. [...]
Luxembourg, 22 February 2021
The Jean Boulle Group (“the Group”) is pleased to confirm the appointment of Jean-Raymond Boulle to the Board of the Corporate Council on Africa (“CCA”). [...]
Jean Boulle Medtech company VDYNE obtains significant investment from a large global medical device company to close $21 million financing for human trials of ground breaking transfemoral tricuspid heart valve replacement technology
Jean Boulle Medtech Ltd is pleased to announce that VDYNE, Inc. ("VDYNE" or “the Company”), a privately held medical device company founded by Jean Boulle Medtech to develop a transcatheter replacement tricuspid valve, has closed a $21 million, heavily subscribed Series C financing. [...]
Copyright © 2019 Jean Boulle Group. All rights reserved.